For patients with eosinophilic granulomatosis with polyangiitis (EGPA), rituximab is not superior to the conventional remission induction strategy, according to a study published online July 29 in the ...
A U.S. soldier watches Ukrainian artillerymen fire the M109 self-propelled howitzer at Grafenwoehr Training Area, Germany, on May 12, 2022. (Sgt. Spencer Rhodes/U.S. Army) FORT LIBERTY, N.C. — The U.S ...
Investor-owned electric utilities have announced record-breaking capital spending plans. The EEI (Edison Electric Institute) said its members would spend $186 billion in 2024 and a bit more in 2025.
Why Traditional SEO Fails in AI Search - The Query Fan-Out Framework Explained Coral Springs, United States - July 4, ...
As a global creative consultancy, frog sees many businesses grapple with traditional growth strategies. Here’s what we’ve learned about what better growth strategy looks like. Spending decades ...
Rituximab did not show superiority over conventional therapy in inducing remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Both treatment groups had similar remission ...
At the Munich Security Conference last week, Europeans focused on meeting their own security needs in the face of continued threats from Moscow and rapidly eroding trust with Washington. Among the ...
Rituximab no better than glucocorticoids alone for inducing remission in patients with eosinophilic granulomatosis with polyangiitis. HealthDay News — For patients with eosinophilic granulomatosis ...